What does Repligen company do?
Repligen is a bioprocessing-focused life sciences company bringing expertise and innovation to our customers since 1981. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs.
Is Repligen a buy?
Repligen has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.
How many employees does Repligen have?
1162014
Repligen/Number of employees
When did Repligen go public?
A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of February 2014, Repligen employed 116 people, about 50% of these based in Sweden….Repligen.
| Type | Public company |
|---|---|
| Number of employees | 116 (2014) |
| Website | www.repligen.com |
Who founded Repligen?
Alexander Rich
Paul Schimmel
Repligen/Founders
When was Repligen founded?
1981
Repligen/Founded
Repligen was founded in 1981 by two distinguished scientists who pioneered breakthrough advances in science and technology. Alexander Rich was co-Chair of the Repligen Board of Directors until 2014. He was a Professor at the Massachusetts Institute of Technology since 1958.
Is rgen overvalued?
Valuation metrics show that Repligen Corporation may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors.
Why is rgen falling?
RGEN stock reached its all-time high of around $327 just after the announcement, but profit-booking at higher levels resulted in RGEN stock falling to levels of $259 currently.
Is Repligen a good company?
Is Repligen a good company to work for? Repligen has an overall rating of 3.2 out of 5, based on over 61 reviews left anonymously by employees. 57% of employees would recommend working at Repligen to a friend and 80% have a positive outlook for the business.
What does Repligen make?
biological drugs
Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company’s bioprocessing business consist of four franchises, Filtration; Chromatography; Process Analytics; and Proteins.
Why is RGEN falling?
What is Repligen technology?
Technologies :: Repligen Inspiring advances in bioprocessing, Repligen is a leader in pre-packed chromatography, bioprocessing filtration technologies, hollow fiber filters, flat sheet cassettes. You are using an unsupported browser.
What is Repligen® fluid management?
Fluid management is critical in upstream and downstream biopharmaceutical manufacturing processes. Repligen fluid management solutions include custom and standard ProConnex ® Flow Paths, molded components and tubing, bottles and containers, innovative valves, and process equipment.
Why chooserepligen?
Repligen develops and manufactures products for the biopharmaceutical industry under an ISO 9001 quality management system. We focus on the timely delivery of high quality, consistent and robust products, and ensuring business continuity for our customers.
Why choose Repligen Breda?
Repligen is now the only supplier with column packing capabilities on two continents with the new OPUS ® Manufacturing Center of Excellence in Breda, The Netherlands. Repligen Breda simplifies European supply chain logistics by enabling regional column packing.